Publications by authors named "Allison B Reiss"

Impaired cognition is a key trait of the diseases of aging and is an important quality of life factor for older adults and their families. Over the past decade, there has been an increasing appreciation for the role of the microbiome in cognition, as well as emerging evidence that probiotics, such as those in yogurt and other dairy products, can have a positive impact on cognitive function. However, it is unclear to what extent the consumption of yogurt is associated with improved cognitive function in older adults.

View Article and Find Full Text PDF

Alzheimer's disease (AD) is an incurable and progressive neurodegenerative disease with increasing prevalence worldwide. Previous trials of anti-amyloid and anti-tau immunotherapy indicate that additional research needs to be conducted on other mechanisms to find curative or disease-modifying therapy. This review focuses on apolipoprotein E (ApoE), a critical protein in brain lipid metabolism that acts specifically in the clearance and transport of lipids and cholesterol.

View Article and Find Full Text PDF
Article Synopsis
  • - Nilotinib is an FDA-approved drug for chronic myeloid leukemia that may have potential neuroprotective effects, leading researchers to investigate its use in treating Alzheimer's disease (AD) and Parkinson's disease (PD).
  • - The study examined nilotinib's impact on amyloid processing and mitochondrial function in SH-SY5Y neuroblastoma cells, finding no significant changes in key gene expressions related to amyloid-β processing or neuronal health.
  • - While BACE1 and ADAM10 proteins were increased at certain nilotinib concentrations, overall results suggest that nilotinib does not effectively provide neuroprotection.
View Article and Find Full Text PDF
Article Synopsis
  • Hyperglycemia in diabetes leads to the buildup of Advanced glycation end products (AGEs), which is linked to cardiovascular issues via their impact on cholesterol levels.
  • The study investigated how plasma from poorly controlled adolescents with type 1 diabetes affects cholesterol handling in human macrophages, using THP-1 cells in a lab setting.
  • Findings revealed that T1D plasma increased certain proteins related to cholesterol uptake and foam cell formation, suggesting that AGEs exacerbate atherosclerosis in diabetes by disrupting cholesterol transport processes.
View Article and Find Full Text PDF
Article Synopsis
  • - Despite improvements in treating rheumatoid arthritis, the disease increases the likelihood of developing cardiovascular disease (CVD), partly due to inadequacies in current screening and clinical guidelines.
  • - Traditional CVD risk factors overlook the heightened risk in rheumatoid arthritis patients, emphasizing the need for better assessment methods that consider systemic inflammation and its role in atherosclerosis.
  • - The review discusses treatment options for rheumatoid arthritis, their cardiovascular effects, and presents a proposed clinical strategy for screening and managing CVD risk in these patients, highlighting the urgency for further research in this area.
View Article and Find Full Text PDF

The effect of airborne exposure on the eye surface is an area in need of exploration, particularly in light of the increasing number of incidents occurring in both civilian and military settings. In this study, in silico methods based on a platform comprising a portfolio of software applications and a technology ecosystem are used to test potential surface ocular toxicity in data presented from Iraqi burn pits and the East Palestine, Ohio, train derailment. The purpose of this analysis is to gain a better understanding of the long-term impact of such an exposure to the ocular surface and the manifestation of surface irritation, including dry eye disease.

View Article and Find Full Text PDF

#brain #injury in the #football #player - we need better #diagnosis and #prevention. #view our #latest #publication in the #journal Concussion @futuresciencegp on @thegame #Blood test #biomarker #innovation #safety @NFL.

View Article and Find Full Text PDF

Chronic kidney disease (CKD) is a slowly progressive condition characterized by decreased kidney function, tubular injury, oxidative stress, and inflammation. CKD is a leading global health burden that is asymptomatic in early stages but can ultimately cause kidney failure. Its etiology is complex and involves dysregulated signaling pathways that lead to fibrosis.

View Article and Find Full Text PDF

Alzheimer's disease (AD) is a progressive and incurable neurodegenerative disorder that primarily affects persons aged 65 years and above. It causes dementia with memory loss and deterioration in thinking and language skills. AD is characterized by specific pathology resulting from the accumulation in the brain of extracellular plaques of amyloid-β and intracellular tangles of phosphorylated tau.

View Article and Find Full Text PDF

Prostate cancer is the second leading cause of cancer death in men in the United States. Androgen deprivation therapy (ADT) is currently the primary treatment for metastatic prostate cancer, and some studies have shown that the use of anti-androgen drugs is related to a reduction in cognitive function, mood changes, diminished quality of life, dementia, and possibly Alzheimer's disease. ADT has potential physiological effects such as a reduction in white matter integrity and a negative impact on hypothalamic functions due to the lowering of testosterone levels or the blockade of downstream androgen receptor signaling by first- and second-generation anti-androgen drugs.

View Article and Find Full Text PDF

Mitochondrial degeneration in various neurodegenerative diseases, specifically in Alzheimer's disease, involves excessive mitochondrial fission and reduced fusion, leading to cell damage. P110 is a seven-amino acid peptide that restores mitochondrial dynamics by acting as an inhibitor of mitochondrial fission. However, the role of P110 as a neuroprotective agent in AD remains unclear.

View Article and Find Full Text PDF

Mild traumatic brain injury (TBI) and concussion can have serious consequences that develop over time with unpredictable levels of recovery. Millions of concussions occur yearly, and a substantial number result in lingering symptoms, loss of productivity, and lower quality of life. The diagnosis may not be made for multiple reasons, including due to patient hesitancy to undergo neuroimaging and inability of imaging to detect minimal damage.

View Article and Find Full Text PDF

Dysregulated cholesterol metabolism represents an increasingly recognized feature of autism spectrum disorder (ASD). Children with fetal valproate syndrome caused by prenatal exposure to valproic acid (VPA), an anti-epileptic and mood-stabilizing drug, have a higher incidence of developing ASD. However, the role of VPA in cholesterol homeostasis in neurons and microglial cells remains unclear.

View Article and Find Full Text PDF

Although there are many biochemical methods to measure amyloid-β (Aβ)42 concentration, one of the critical issues in the study of the effects of Aβ42 on the nervous system is a simple physiological measurement. The in vitro rat sciatic nerve model is employed and the nerve action potential (NAP) is quantified with different stimuli while exposed to different concentrations of Aβ42. Aβ42 predominantly reduces the NAP amplitude with minimal effects on other parameters except at low stimulus currents and short inter-stimulus intervals.

View Article and Find Full Text PDF

SARS-CoV-2, a single-stranded RNA coronavirus, causes an illness known as coronavirus disease 2019 (COVID-19). Long-term complications are an increasing issue in patients who have been infected with COVID-19 and may be a result of viral-associated systemic and central nervous system inflammation or may arise from a virus-induced hypercoagulable state. COVID-19 may incite changes in brain function with a wide range of lingering symptoms.

View Article and Find Full Text PDF
Article Synopsis
  • Current Alzheimer's disease (AD) treatments mainly provide symptom relief without altering the disease's progression, prompting researchers to explore innovative therapies focused on inflammation and neuro-regeneration.
  • Recent FDA-approved anti-amyloid drugs like aducanumab and lecanemab show unclear effectiveness in real-world settings and have significant side effects, highlighting the need for better early-stage interventions.
  • Ongoing research includes strategies to target neuroinflammation, such as modifying immune responses, enhancing autophagy, and lifestyle interventions like diet and exercise, in hopes of preserving cognitive function.
View Article and Find Full Text PDF

Cardiovascular disease (CVD) is the leading cause of morbidity and mortality globally. In recent decades, clinical research has made significant advances, resulting in improved survival and recovery rates for patients with CVD. Despite this progress, there is substantial residual CVD risk and an unmet need for better treatment.

View Article and Find Full Text PDF

The surface of the eye is directly exposed to the external environment, protected only by a thin tear film, and may therefore be damaged by contact with ambient particulate matter, liquids, aerosols, or vapors. In the workplace or home, the eye is subject to accidental or incidental exposure to cleaning products and pesticides. Organic matter may enter the eye and cause infection.

View Article and Find Full Text PDF

Traumatic brain injury (TBI) results when external physical forces impact the head with sufficient intensity to cause damage to the brain. TBI can be mild, moderate, or severe and may have long-term consequences including visual difficulties, cognitive deficits, headache, pain, sleep disturbances, and post-traumatic epilepsy. Disruption of the normal functioning of the brain leads to a cascade of effects with molecular and anatomical changes, persistent neuronal hyperexcitation, neuroinflammation, and neuronal loss.

View Article and Find Full Text PDF

Primary care professionals play a critical role in the care of their patients. In clinical practice, early detection and diagnosis of Mild Cognitive Impairment, Alzheimer's disease and related dementia are often missed or delayed. Disclosure of diagnosis is not timely or not revealed.

View Article and Find Full Text PDF